Drug inhibition of catecholamine-induced metabolic effects in humans.
D000328:Adult; D001786:Blood Glucose; D002395:Catecholamines / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004837:Epinephrine / Q000494:pharmacology; D005227:Fatty Acids / Q000097:blood*; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D010919:Placebos; D011433:Propranolol / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*
D001786:Blood Glucose; D002395:Catecholamines; D005227:Fatty Acids; D010919:Placebos; D013565:Sympatholytics; D011433:Propranolol; D008729:Methoxamine; D007545:Isoproterenol; D004837:Epinephrine